ClinicalTrials.Veeva

Menu

Hyperoxemia and Ventilator-associated Pneumonia (SOH-VAP)

U

University Hospital, Lille

Status

Completed

Conditions

Mechanical Ventilation

Study type

Observational

Funder types

Other

Identifiers

NCT03434821
2016_73
2017-A01934-49 (Other Identifier)

Details and patient eligibility

About

The aim of this prospective cohort single-center observational study is to determine the impact of hyperoxemia on ventilator-associated pneumonia (VAP) occurrence.

  • SpO2 will be continuously recorded in order to determine the percentage of time spent with hyperoxemia.
  • Patients with VAP will be prospectively identified.
  • Patient characteristics and risk factors for VAP will be prospectively collected.
  • Oxidant stress will be prospectively investigated in study patients: glutathion peroxidase (GPX), plasmatic superoxyde dismutase (SOD), total plasmatic antioxidant status (SAT) and urinary 8-isoprostanes will be performed at ICU admission, once a week, and at VAP occurrence.

Patients with VAP will be compared with those with no VAP

Enrollment

534 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients admitted to the ICU
  • Expected duration of mechanical ventilation > 48h
  • Signed informed consent
  • Social insurance

Exclusion criteria

  • Pregnancy or breast feeding
  • No informed consent
  • Hyperbaric oxygen treatment
  • Prisoners and patients under guardianship

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems